Exonate
focuses on the discovery and development of treatment for retinal neovascular diseases... Read moreExonate
focuses on the discovery and development of treatment for retinal neovascular diseases... Read more
News
Jul 16, 2024
PharmaTimes
Exonate: Dr Rafiq Hasan
Mar 07, 2024
Eyewire News
Exonate: Phase 1b/2a Trial of Exonate's Eye Drop Demonstrate Safety and Biological Activity in Treatment of DR and DME
Nov 30, 2023
Outsourcing-Pharma
Exonate: First eye drop for diabetic macular oedema on horizon after successful trial
Nov 28, 2023
News-Medical
Exonate: Exonate announces successful completion of Phase Ib/IIa trial in diabetic macular oedema
Feb 04, 2021
PharmaTimes
Exonate: Exonate launches diabetic macular oedema trial
Feb 02, 2021
Seeking Alpha
Exonate: Dosing underway in Janssen, Exonate's study of EXN 407 in diabetic macular oedema
Jan 24, 2020
Cambridge Independent
Exonate: Eye drops for retinal vascular diseases to be developed by Exonate and Jannssen
Jan 13, 2020
East Midlands Business LInk
Exonate: University of Nottingham spin out secures major collaboration deal with Johnson and Johnson
Jan 03, 2019
Manufacturing Chemist
Exonate: Exonate closes �1.5 million fundraiser
Jan 03, 2019
pharmatimes
Exonate: Exonate fundraises £1.5 million
Exonate Competitors
1
2
3
4
5
6
7
8
9
10